Recruiting Ankylosing Spondylitis Studies in Madison
About Ankylosing Spondylitis Clinical Trials in Madison
Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.
There are currently 9 ankylosing spondylitis clinical trials recruiting participants in Madison, WI. These studies are seeking a combined 619 participants. Research is being sponsored by EyeBiotech Ltd., QED Therapeutics, a BridgeBio company, QED Therapeutics, Inc., a Bridgebio company and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.
Ankylosing Spondylitis Clinical Trials in Madison — FAQ
Are there ankylosing spondylitis clinical trials in Madison?
Yes, there are 9 ankylosing spondylitis clinical trials currently recruiting in Madison, WI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Madison?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Madison research site will contact you about next steps.
Are clinical trials in Madison free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Madison studies also compensate for your time and travel.
What ankylosing spondylitis treatments are being tested?
The 9 active trials in Madison are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.
Data updated July 17, 2026 from ClinicalTrials.gov